Pellegrini L
School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom; Centre for Neuropsychopharmacology and Psychedelic Research, Hammersmith Hospital Campus, Imperial College, London, United Kingdom; Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy; Azienda Sanitaria Universitaria Giuliano-Isontina - ASUGI, UCO Clinica Psichiatrica, Trieste, Italy. Electronic address: luca.pellegrini@units.it.
ArticlePsilocybin
Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.
ArticlePsilocybin